Overview

Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate the influence of anti tumor necrosis factor-alpha (TNF-α) treatment on blood pressure, endothelial function and immune cell phenotype in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Phase:

Phase 4

Details

Lead Sponsor:

Jagiellonian University

Collaborator:

Departmet of Rheumatology, J Dietl Hospital, Krakow, Poland

Treatments:

Adalimumab
Certolizumab Pegol
Etanercept
Infliximab